Initial dose of antidepressant and suicidal behavior in youth start low, go slow

JAMA Internal Medicine

Volumn 174, Issue 6, 2014, Pages 909-911

  Brent, David A ^a,b   Gibbons, Robert ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE;

DEPRESSION; DRUG EFFICACY; HUMAN; NOTE; PRIORITY JOURNAL; RISK; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; HUMANS; MALE; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS;

EID: 84902142260     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.14016     Document Type: Note

References (8)

1. MillerM, Swanson SA, Azrael D, Pate V, Stürmer T. Antidepressant dose, age, and the risk of deliberate self-harm [published online April 28, 2014]. JAMA Intern Med. doi:10.1001/jamainternmed.2014.1053.
2. Birmaher B, Brent D, BernetW, et al AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J AmAcad Child Adolesc Psychiatry. 2007;46(11):1503-1526.
3. Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry. 2009;70(8):1069-1077.
4. Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012;69(6): 572-579.
5. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009;166(1): 42-49.
6. Ruhé HG, Huyser J, Swinkels JA, Schene AH. Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review. Br J Psychiatry. 2006;189:309-316. (Pubitemid 44606743)
7. Sakolsky DJ, Perel JM, Emslie GJ, et al. Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol. 2011;31(1):92-97.
8. Ostad Haji E, Tadic A,Wagner S, et al. Early improvement and serum concentrations of citalopram to predict antidepressant drug response of patients with major depression. Pharmacopsychiatry. 2013;46(7):261-266.